Paediatriac Malignant Disease Flashcards

1
Q

What are the core clinical problems that causes paediatric malignant disease?

A

1 Anaemia
4 Dying patient
5 Splenomegaly
8 Lymphadenopathy
20 Headache
60 Abdominal mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Childhood cancer statistics

A

Cancer is rare in children
Less than 1% of all cases of malignancy

Average GP – will see 1 case in 15 years
Average DGH – will see 5 cases a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When a diagnosis of cancer is made or suspected - what happens?

A

most children are referred to a regional centre.
There are 21 such centres in the UK and Ireland.
Children may receive all their treatment at the regional centre, or this may be done in conjunction with their local hospital in a variety of “shared care” arrangements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mortality rates in children

A

In 1st year mortality
580 deaths per 100,000 infants (UK)

After 1st year risk of death reduces:
27 deaths per 100,000 in children aged 1-4
12 deaths per 100,000 in children aged 5-14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Main causes of death in children (1999)

A

Injury 23.1%
Cancer 18.4%
CNS disorders 13%
Respiratory disease 9.6% (includes pneumonia)
Congenital anomalies 8.2%
Infectious causes 6.3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the implications of improving survival?

A

Survival has improved over last 30 years
Today > 75% are cured
1 in 900 adults had cancer as child

Late effects from treatment
Some are well recognised
New problems identified (longer survival, new therapy)
Life long follow up essential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Differences in cancers between children and adults?

A

Carcinomas very rare in children
Embryonal tumours very rare in adults
- Wilms
- Neuroblastoma
- Rhabdomyosarcoma
Leukaemia occurs at all ages
- More common in younger children
Bone tumours and lymphomas
- Peak incidence: early adolescence, early adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference in biological behaviour in lymphoma between children and adults

A

with indolent “low grade” lymphomas being much more common in adults and extremely rare in childhood where “high grade” types predominate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Difference in leukaemia between children and adults

A

children the predominant type is acute lymphoblastic leukaemia, which is much less common in adults. Chronic leukaemia is extremely rare in childhood, in particular chronic lymphoid leukaemia is not seen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common malignancy seen in childhood?

A

Acute leukaemia is the commonest malignancy seen in childhood – accounting for around 30-33% with the majority of these (80-85%) being acute lymphoblastic leukaemia. The peak incidence of acute leukaemia in “resource rich” countries is 2-6 years. This is not seen in less privileged countries. Acute myeloblastic leukaemia does not have such variation in incidence. Environmental factors are responsible for the very high incidence of B cell lymphomas in equatorial Africa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Some common cancer incidence

A

Leukaemia
CNS tumours
Lymphoma
Neuroblastoma
Soft tissue sarcoma
Wilms
Bone tumours
Retinoblastoma
Other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which tumour’s incidence seems to be increasing?

A

The incidence of some tumours appears to be increasing. For example there has been an average 0.7% annual increase in ALL of precursor B cell origin and Hodgkins lymphoma (1.2% per year) in the North West of England since the mid 1950s. Other studies have shown small increases in incidence of other solid tumour types. The reasons for these increases are not clear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the aetiology of childhood cancers

A

Most cases – cause is unknown
< 5% due to identifiable genetic abnormality
Double Hit theory: interaction between environment and genetic susceptibility
Mutations in cellular genes
Oncogenes, tumour suppressor genes
Inherited (e.g. retinoblastoma) or sporadic
Some children at increased risk of cancer
Downs, immune-compromised, NF1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

WAGR syndrome and cancer

A

Studies of children with the WAGR syndrome (Wilms tumour, aniridia, genital abnormalities and mental retardation) led to greater understanding of genetics and cancer. A number of children with the syndrome were found to have a deletion of 11p13, and subsequently the WT1 gene was located to this region. Mutations of this gene are found in the tumour cells of many (but not all) children with Wilms who do not have the WAGR or similar syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the presentation of children with possible malignant disease?

A

Localised mass
- Lymphadenopathy
- Organomegaly
- Soft tissue or bony mass
Problems from disseminated disease
- Bone marrow infiltration
Problems from localised mass
- Airway obstruction from lymphadenopathy
Cervical lymphadenopathy is not uncommon in childhood but most children with this do not have cancer
Abdominal distension may be due to tumour in organ such as kidney, or constipation
Aches and pains are a frequent complaint in childhood – only very rarely due to leukaemia
Breathlessness and wheeze much more likely to be due to asthma than lymphoma
Headaches very unlikely to be due to CNS tumour, but frequently are present in child with brain tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some possible presentations of malignant disease in paediatrics?

A

Recent URTI, pale & tired
Post viral or leukaemia?
Lump in neck, otherwise well
Atypical mycobacteria or Hodgkin’s?
Early morning headache
Sinusitis or brain tumour?
Recurrent fever & bone pain
Arthritis, Leukaemia, Ewing’s, Neuroblastoma?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Easier differentials in those with paediatric malignancy?

A

Abnormal red reflex in eye
Retinoblastoma
Proptosis
Infection, Neuroblastoma, Rhabdomyosarcoma
Recurrent discharging ear
Infection, Rhabdomyosarcoma, LCH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Key messages to remember for children with possible malignancy?

A

Consider malignancy in any child whose condition does not resolve or respond to treatment in the normal way

Do not be afraid to challenge the original diagnosis

If in doubt, retake a full history, from the beginning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Presentation of acute leukaemia?

A

Fever
Fatigue
Frequent infections
Lymphadenopathy
Hepatomegaly and/or splenomegaly
Anaemia
Bruising,petechiae
Bone or joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do children with ALL usually present with?

A

signs and symptoms that reflect bone marrow infiltration and/or extramedullary disease. Because leukaemic blasts replace the bone marrow, patients present with signs of bone marrow failure, including anaemia, thrombocytopenia, and neutropaenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the S + S of CNS involvement?

A

Signs or symptoms of CNS involvement, even when it occurs, are rarely seen at presentation. The signs and symptoms include headache, nausea and vomiting, lethargy, irritability, nuchal rigidity, papilloedema. Cranial nerve involvement (most frequently involves 3rd, 4th, 6th and 7th nerves) may occur. Rarely there may be an intracranial or spinal mass, which causes symptoms due to nerve compression.
Testicular involvement at diagnosis is rare. However, if present, it appears as painless testicular enlargement and is most often unilateral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the clinical manifestations of ALL in children?

A

fatigue and pallor, petechiae and bleeding, and fever. In addition, leukaemic spread may manifest as lymphadenopathy and hepatosplenomegaly. Other signs and symptoms of leukemia include weight loss, bone pain, and dyspnoea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the investigations of ALL?

A

Blood film
Serum chemistry
CXR
Bone marrow aspirate
Lumbar puncture
Imaging studies: Chest radiography Procedures: Bone marrow aspirate & biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What happens in chest radiography?

A

Evaluate for a mediastinal mass. In general, no other imaging studies are required. If physical examination reveals enlarged testes, then ultrasound of testes should be done - to evaluate for testicular infiltration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What happens in bone marrow aspirate & biopsy?

A

The results confirm the diagnosis of ALL. In addition, special stains (immunohistochemistry), immunophenotyping, cytogenetic analysis, and molecular analysis help in classifying each case.
Lumbar puncture with cytospin morphologic analysis: These tests are performed before systemic chemotherapy is administered to assess for CNS involvement and to administer intrathecal chemotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

ALL treatment

A

Chemotherapy – 5 phases
Induction, Consolidation, Interim maintenance
Delayed intensification, Maintenance

Haemopoietic stem cell transplantation
High risk patients in first remission
Relapsed patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What happens in the induction stage of chemotherapy?

A

goal of induction is to achieve remission or <5% blasts in the bone marrow. Induction therapy generally consists of 3-4 drugs, which may include a glucocorticoid, a vincristine, an asparaginase, and possibly an anthracycline (depending on whether they are considered at higher risk of relapse). This type of therapy induces complete remission in > 98%.

28
Q

Goal of consolidation in chemo

A

Consolidation (i.e., intensification) therapy is given soon after remission is achieved to further reduce the leukaemic cell burden before the emergence of drug resistance and relapse in sanctuary sites (e.g., testes, CNS). In this phase of therapy, the drugs are usually given at doses higher than those used during induction, or the patient is given different drugs (e.g., high-dose methotrexate (MTX) and 6-mercaptopurine (6-MP), epipodophyllotoxins with cytarabine, or multi-agent combination therapy). Consolidation therapy, first used successfully to treat patients with high-risk disease, also appears to improve the long-term survival of patients with standard-risk disease. The addition of intensive reinduction therapy (administered soon after remission is achieved) is similarly beneficial for patients in both risk groups

29
Q

Goal of interim maintenance in chemo

A

oral medications are administered to maintain remission and allow the bone marrow to recover. This occurs for 4 weeks and is followed by delayed intensification, which is aimed at treating any remaining resistant leukemia cells.

30
Q

Goal of maintenance in chemo

A

The last phase of treatment is maintenance. This consists of LPs with intrathecal MTX every 3 months, monthly vincristine, daily 6-MP, and weekly MTX

31
Q

What is the presentation of CNS tumours in children - usually symptoms of raised ICP

A

Headache
often worse lying down
Vomiting
especially early morning
Papilloedema
Squint
Nystagmus
Ataxia
Personality or behaviour change

32
Q

What are the most common solid tumours in children

A

Brain tumours
Approximately 600 children in the United Kingdom are diagnosed with a brain tumour each year. Today, more than half of all children diagnosed with a brain tumour will be cured of the disease. However, because of their location, treatment for brain tumours is particularly complex.

33
Q

What are the challenges many children who are treated for brain tumours experience?

A

significant long-term problems, such as changes in intellectual and motor function. These children require ongoing assessment and specialized care to help them function at school and throughout life as best as possible.
Resection is carried out usually as first therapeutic/diagnostic procedure wherever possible – sometimes may be too hazardous to do this- depending on site – such as brain stem or pineal.

34
Q

What is the management of children with brain tumours?

A

Most children with malignant brain tumours require surgery, radiotherapy and chemotherapy
Chemotherapy is increasingly used in addition to or instead of radiotherapy.

35
Q

When should we scan a child with a headache?

A

If also papilloedema, decreased acuity, visual loss
If also other neurological signs (or they develop)
If recurrent and/or early morning
If associated with vomiting
- if persistent, more frequent, preceded by headache
If also have short stature / decelerated linear growth
If have symptoms of diabetes insipidus
If age < 3 years
If child has neurofibromatosis (NF1)

36
Q

Difference between CNS tumours in children and adults?

A

CNS tumours in children are nearly always primary tumours in contrast to adults where many are metastatic.
Again in contrast to adults where most tumours arise in the cerebral hemispheres, the majority (>60%) arise below the tentorium.

37
Q

CNS tumours treatment

A

Surgery
- Resection
- VP shunt
Chemotherapy
- Single agent
- Combination treatment
Radiotherapy
- For malignant tumours in older children
- Whole brain not used in very young

38
Q

What is involved in surgery of CNS tumours?

A

Treatment of brain tumours usually begins with surgery to remove all or part of the tumour while minimising damage to healthy tissue. Some tumours can be removed completely, and others can be removed only partially, or a biopsy only may be done. Some may not even be biopsied because the site is associated with significant risk e.g. intrinsic brain stem tumours.

39
Q

Radiotherapy in CNS tumours

A

Radiation uses high-energy X-rays to destroy tumour cells and is often used after surgery as treatment for malignant CNS tumours. It may be used alone, or with chemotherapy, to treat tumours particularly when surgery is not possible. Radiotherapy causes damage to the developing nervous system, and so is not considered appropriate for very young children.

40
Q

Chemotherapy in CNS tumours

A

Increasingly chemotherapy is used to treat CNS tumours. Unfortunately many drugs that are effective against other malignant disease are ineffective in treatment of CNS tumours, mainly because they do not penetrate the blood brain barrier. This has limited the use of chemotherapy, but more recently developed drugs that have shown promise in pre-clinical studies are under investigation in clinical trials.

41
Q

What is most lymphadenopathy in children due to?

A

Most lymphadenopathy in children due to benign self-limited disease, mainly viral or bacterial infections.

42
Q

What is lymphadenopathy caused by?

A

caused by increase in normal lymphocytes & macrophages during response to an antigen such as viral illness, nodal infiltration by inflammatory cells in response to an infection in the nodes themselves (lymphadenitis), proliferation of neoplastic lymphocytes or macrophages (lymphoma), or infiltration of nodes by metabolite-laden macrophages in storage diseases (Gaucher disease).

43
Q

Causes of lymphadenopathy?

A

Very common in childhood (up to 50%)
Mostly due to self limiting benign cause
Other causes
HIV infection
Auto immune conditions
Storage disorders
Malignancy

44
Q

What is localised lymphadenitis most often caused by?

A

Localized lymphadenitis is most often caused by staphylococci and beta-hemolytic streptococci.

45
Q

When can you be worried about cancer with lymphadenopathy?

A

Enlarging node without clear infective cause
Persistently enlarged node
Unusual site e.g. supraclavicular
If have associated symptoms and signs
Fever, weight loss, enlarged liver/spleen
If CXR abnormal

46
Q

Where is generalised lymphadenopathy present in?

A

Generalized lymphadenopathy is present at diagnosis in two thirds of children with acute lymphoblastic leukemia (ALL) and in one third of children with acute myeloblastic leukemia (AML). Abnormalities of peripheral blood counts usually lead to the correct diagnosis.
Lymphomas more often present with regional lymphadenopathy, but generalized lymphadenopathy occurs.

47
Q

What are the constitutional signs

A

fever, anorexia, nonspecific aches and pains, weight loss, and night sweats

48
Q

Hodgkins in children

A

Only one third of children with Hodgkin disease and 10% with non-Hodgkin lymphoma display constitutional symptoms. Malignancies usually present with nodes that tend to be firmer and less mobile or matted; however, this finding can be misleading. Benign reactive lymph nodes may be associated with fibrotic reactions that make them firm.

49
Q

What is paediatric lymphoma therapy?

A

Chemotherapy
Determined by histology and stage
Radiotherapy
Hodgkin’s – to residual bulk disease
NHL - rarely
Surgery – mainly limited to biopsy
High dose therapy mainly for relapse

50
Q

What is standard treatment for non-Hodgkin’s lymphoma?

A

Standard treatment for non-Hodgkin’s lymphoma is combination chemotherapy (using multiple drugs). Radiation therapy is rarely used to treat non-Hodgkin’s lymphoma except occasionally when the disease has spread to the central nervous system (brain and spinal cord) or testes.The cure rate for non-Hodgkin’s lymphoma ranges from 65 to 100 percent of patients depending on the type of non-Hodgkin’s lymphoma, the extent of disease at the time of diagnosis and how quickly the lymphoma responds to initial therapy. Initial treatment lasts from several months to a couple of years, depending on the type and extent of the disease.

51
Q

Standard treatment for Hodgkins lymphoma

A

Standard treatment for Hodgkin’s lymphoma is combination chemotherapy (using multiple drugs) along with radiation therapy. Overall, 80 to 98 percent of children and adolescents with Hodgkin’s lymphoma are cured of their disease. The cure rate depends mainly on the stage of the lymphoma, presence of associated symptoms, the size of any tumors, and other factors about the child’s disease.

52
Q

What do we do when a child presents with an abdominal mass?

A

Child may present with mass only or with additional associated symptoms
Pain, haematuria, constipation, hypertension, weight loss
Ultrasound scan useful initial investigation
CT scans
Biopsy

53
Q

Child with abdominal distension/mass differentials?

A

Hepatoblastoma
Wilms tumour
Neuroblastoma
Lymphoma/leukaemia
Sarcoma
Constipation
Enlarged kidneys – polycystic disease

54
Q

Treatment for neuroblastoma to children

A

Surgery
Primary - if resectable
Following chemotherapy
Chemotherapy
Type determined by stage and biology
High dose with HPSC - high risk groups
Radiotherapy
Mainly for high risk group or at relapse

55
Q

What is given to children with low risk neuroblastoma?

A

Children at low risk usually require only surgery. Infants with some residual neuroblastoma after surgery can often be watched without treatment because the tumour will often spontaneously disappear. A short course of chemotherapy might be given to those few children that have symptoms from the tumour. For example, if the tumour is causing cord compression or respiratory symptoms
Chemotherapy may also given if resection is not possible. Infants with 4S disease and no symptoms may be watched with no treatment, because often the cancer disappears spontaneously

56
Q

Intermediate risk neuroblastoma treatment

A

For children at intermediate risk, 4 to 8 cycles of chemotherapy are usually given before or after surgery to control the disease. The chemotherapy is usually similar to that used for low risk disease. Second look surgery or radiation therapy may also be used.

57
Q

High risk neuroblastoma treatment for children

A

For children at high risk, very intensive chemotherapy along with haemopoietic progenitor (stem) cell transplant (either bone marrow or peripheral blood) is used in addition to standard chemotherapy. Surgery and/or radiation may be part of this treatment regimen. Biologic agents such as 13-cis retinoic acid are often given for 6 months after therapy is completed

58
Q

Wilms tumour treatment in children

A

Chemotherapy
Prior to surgery
Following surgery
Chemotherapy protocols vary from study to study; however, the main agents administered include vincristine, dactinomycin, and doxorubicin. Cyclophosphamide, etoposide and carboplatin are used for some patients at higher risk of standard treatment failure.

Surgery
Nephrectomy
Partial nephrectomy if bilateral
Involves nephrectomy for unilateral disease, or partial nephrectomy if disease is bilateral (occurs in < 5% of patients).

Radiotherapy
If residual abdominal or pulmonary disease
Radiation therapy is restricted for treatment of higher-stage (III and IV) disease

59
Q

Differences between neuroblastoma and Wilms tumour

A

Neuroblastoma has significantly less good outcome in comparison to Wilms tumour.
Survival chance is largely determined by stage and age. Infants have significantly better prognosis that older children, even when they have metastatic disease.
Unfortunately a significant proportion of children with neuroblastoma present with metastatic disease.
Only a minority of children over the age of 12 months who present with metastatic neuroblastoma are cured, even when given very intensive treatment.

Majority of children with Wilms will be cured, and treatment has been refined over the last few years, so that patients with better prognosis (low stage and favourable histology) are currently treated with less chemotherapy and radiotherapy than has been used in the past. Children with metastatic disease and/or adverse histology are given more intensive treatment

60
Q

What is retinoblastoma?

A

Loss of red reflex and squint
RB1 gene
Familial (40%) v’s Sporadic
Multimodal therapy

61
Q

Most common symptoms of retinoblastoma?

A

leukocoria – loss of red reflex (also called cat’s eye)
Strabismus
pain or redness around the eye
poor vision or change in child’s vision
Treatment may include one or more of the following:
chemotherapy
radiation therapy
laser therapy
phototherapy
thermal therapy
cryotherapy
surgery - enucleation of eye

62
Q

Late effects of treatment

A

Endocrine - growth and development
Intellectual
Cardiac toxicity
Renal toxicity
Fertility
Psychological

63
Q

RFs for late effects:

A

Tumour-related factors
Direct tissue effects.
Tumour-induced organ dysfunction.
Mechanical effects.

64
Q

Treatment-related factors

A

Radiation therapy: Total dose and fraction size, organ or tissue volume, and machine energy are the most critical factors.
Chemotherapy: type, single and cumulative dose and schedule may modify risk.
Surgery: Technique and site are relevant.

65
Q

Host-related factors

A

Developmental status.
Genetic predisposition.
Inherent tissue sensitivities and capacity for normal tissue repair.
Function of organs not affected by radiation therapy or chemotherapy.
Premorbid state.